Literature DB >> 11328454

The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation.

M Jászberényi1, E Bujdosó, G Telegdy.   

Abstract

The role of neuropeptide Y (NPY) in the mediation of orexin-induced hypothalamic-pituitary-adrenal (HPA) activation was investigated in the rat. The HPA system was stimulated by intracerebroventricular (i.c.v.) administration of orexin-A or orexin-B (140 or 280 pmol, respectively) and the plasma concentration of corticosterone was used as an index of the degree of activation. i.c.v. pretreatment with NPY antagonist or NPY antiserum (30 min or 24 h before orexin administration, respectively) inhibited the orexin-induced corticosterone release. The inhibitory actions of the antagonist and the antiserum were revealed by the dose-response curve; the highest concentrations practically abolished the HPA activation evoked by the orexins. These data suggest that the HPA system-stimulating effect of the orexins may be mediated by NPY.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328454     DOI: 10.1046/j.1365-2826.2001.00654.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  3 in total

Review 1.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.

Authors:  Carsten Theodor Beuckmann; Takashi Ueno; Makoto Nakagawa; Michiyuki Suzuki; Shigeru Akasofu
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

3.  Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson's Disease.

Authors:  Mei-Fang Liu; Yan Xue; Cui Liu; Yun-Hai Liu; Hui-Ling Diao; Ying Wang; Yi-Peng Pan; Lei Chen
Journal:  Front Neurosci       Date:  2018-11-15       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.